NOVATest IgG/IgM Antibody Rapid Test Kit (NOVA Test) |
|||
| UNCOV-40 | Atlas Link Technology | 40 Tests | EUR 115 |
Human IgG antibody Laboratories manufactures the pcr test sars-cov2 buy reagents distributed by Genprice. The Pcr Test Sars-Cov2 Buy reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Pcr. Other Pcr products are available in stock. Specificity: Pcr Category: Test Group: Sars-Cov2 Buy
Human Cytomegalovirus Antibody IgG (Anti-CMV IgG) Rapid Test Kit |
||
| Abbexa | 20 tests | EUR 260.4 |
HDV-IgG hepatitis D IgG ELISA test |
||
| Biobase | 96T/Box | Ask for price |
|
Description: ELISA based test for quantitative detection of HDV-IgG hepatitis D IgG |
||
HPV (Human Papilloma Virus Antibody IgG) ELISA test |
||
| Biobase | 96T/Box | Ask for price |
|
Description: ELISA based test for quantitative detection of HPV (Human Papilloma Virus Antibody IgG) |
||
SARS Coronavirus IgG ELISA Kit |
||
| Creative Diagnostics | 96T | EUR 2590.8 |
|
Description: For the qualitative determination of IgG class antibodies against SARS Coronavirus in Human serum or plasma. It is intended for diagnosing and monitoring of patients related to infection by SARS Coronavirus. |
||
MV (Measles Virus Antibody IgG) ELISA test |
||
| Biobase | 96T/Box | Ask for price |
|
Description: ELISA based test for quantitative detection of MV (Measles Virus Antibody IgG) |
||
TB (Mycobacterium Tuberculosis Antibody IgG) ELISA test |
||
| Biobase | 96T/Box | Ask for price |
|
Description: ELISA based test for quantitative detection of TB (Mycobacterium Tuberculosis Antibody IgG) |
||
MP (Mycoplasma Pneumoniae Antibody IgG) ELISA test |
||
| Biobase | 96T/Box | Ask for price |
|
Description: ELISA based test for quantitative detection of MP (Mycoplasma Pneumoniae Antibody IgG) |
||
SARS CoV-2 full length spike protein in LMNG detergent |
|||
| 21-815 | ProSci | 0.1 mg | EUR 1413.6 |
|
Description: The coronavirus, also known as SARS-CoV-2, enters the cell by using its surface SPIKE. SPIKE is processed on the cell's surface by TMPRSS2, a serine protease. It then subsequently binds to ACE2 a cell surface receptor. The Native SPIKE protein is a trimer that is located in the coronavirus membrane. Therefore to get pure & native SPIKE the trimer needs to be kept intact. Our lab staff achieved this in three different ways: MSP nanodiscs, based on MSP proteins Detergent Mycelles, as you can see here Synthetic nanodiscs |
|||
SARS CoV-2 full length spike protein in DIBMA Glycerol |
|||
| 21-816 | ProSci | 0.025 mg | EUR 1703.4 |
|
Description: The coronavirus, also known as SARS-CoV-2, enters the cell by using its surface SPIKE. SPIKE is processed on the cell's surface by TMPRSS2, a serine protease. It then subsequently binds to ACE2 a cell surface receptor. The Native SPIKE protein is a trimer that is located in the coronavirus membrane. Therefore to get pure & native SPIKE the trimer needs to be kept intact. Our lab staff achieved this in three different ways: MSP nanodiscs, based on MSP proteins Detergent Mycelles, as you can see here Synthetic nanodiscs |
|||
SARS-CoV-2 (COVID-19) NSP7 Peptide |
|||
| 9155P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: SARS-CoV-2 (COVID-19) NSP7 Peptide |
|||
SARS-CoV-2 (COVID-19) NSP8 Peptide |
|||
| 9159P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: SARS-CoV-2 (COVID-19) NSP8 Peptide |
|||
SARS-CoV-2 (COVID-19) NSP9 Peptide |
|||
| 9161P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: SARS-CoV-2 (COVID-19) NSP9 Peptide |
|||
SARS-CoV-2 (COVID-19) NSP9 Peptide |
|||
| 9163P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: SARS-CoV-2 (COVID-19) NSP9 Peptide |
|||
SARS-CoV-2 (COVID-19) NSP8 Peptide |
|||
| 9167P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: SARS-CoV-2 (COVID-19) NSP8 Peptide |
|||
SARS-CoV-2 (COVID-19) NSP2 Peptide |
|||
| 9171P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: SARS-CoV-2 (COVID-19) NSP2 Peptide |
|||
SARS-CoV-2 (COVID-19) NSP2 Peptide |
|||
| 9173P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: SARS-CoV-2 (COVID-19) NSP2 Peptide |
|||
SARS-CoV-2 (COVID-19) NSP4 Peptide |
|||
| 9175P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: SARS-CoV-2 (COVID-19) NSP4 Peptide |
|||
SARS-CoV-2 (COVID-19) NSP6 Peptide |
|||
| 9177P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: SARS-CoV-2 (COVID-19) NSP6 Peptide |
|||
SARS-CoV-2 (COVID-19) ORF6 Peptide |
|||
| 9189P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: SARS-CoV-2 (COVID-19) ORF6 Peptide |
|||
SARS-CoV-2 (COVID-19) ORF8 Peptide |
|||
| 9287P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: SARS-CoV-2 (COVID-19) ORF8 Peptide |
|||
SARS-CoV-2 (COVID-19) ORF8 Peptide |
|||
| 9289P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: SARS-CoV-2 (COVID-19) ORF8 Peptide |
|||
SARS-CoV-2 (COVID-19) NSP7 Antibody |
|||
| 9155-002mg | ProSci | 0.02 mg | EUR 229.7 |
|
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP7 plays a role in viral RNA synthesis (3,4,5). It forms a hexadecamer with nsp8 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers. |
|||
SARS-CoV-2 (COVID-19) NSP7 Antibody |
|||
| 9155-01mg | ProSci | 0.1 mg | EUR 594.26 |
|
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP7 plays a role in viral RNA synthesis (3,4,5). It forms a hexadecamer with nsp8 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers. |
|||
SARS-CoV-2 (COVID-19) NSP8 Antibody |
|||
| 9159-002mg | ProSci | 0.02 mg | EUR 229.7 |
|
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP8 plays a role in viral RNA synthesis (3,4,5). Forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers (6). |
|||